Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Matthew Greenhawt and Timothy Vander Leek.
Matthew Greenhawt
Connection Strength
1.601
Timothy Vander Leek
  1. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. J Allergy Clin Immunol Pract. 2021 10; 9(10):3546-3567.
    View in: PubMed
    Score: 0.238
  2. Reply to "How important is the second dose of the COVID-19 mRNA vaccine?" J Allergy Clin Immunol Pract. 2021 06; 9(6):2537-2539.
    View in: PubMed
    Score: 0.237
  3. The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis. J Allergy Clin Immunol Pract. 2021 07; 9(7):2556-2561.
    View in: PubMed
    Score: 0.235
  4. The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World. J Allergy Clin Immunol Pract. 2021 04; 9(4):1438-1441.
    View in: PubMed
    Score: 0.232
  5. A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services. J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2125-2134.
    View in: PubMed
    Score: 0.221
  6. Reply to "Subcutaneous terbutaline as an alternative to aerosolized albuterol". J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2450-2452.
    View in: PubMed
    Score: 0.220
  7. COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic. J Allergy Clin Immunol Pract. 2020 05; 8(5):1477-1488.e5.
    View in: PubMed
    Score: 0.218
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.